Scleroderma

Anti-Acid Therapy Not Recommended in Systemic Sclerosis Interstitial Lung Disease

Researchers evaluated the effect of anti-acid treatment on disease progression in systemic sclerosis interstitial lung disease.

Q&A: Study of Lenabasum in dcSSc Shows Immunosuppressive Therapy Variability by Geographic Region

In a study of lenabasum treatment in systemic sclerosis, researchers evaluated variability of immunosuppressive therapy by geographic region; includes Q&A with study lead author, Dr Christopher Denton.

FDA Grants Orphan Drug Status to Antifibrotic Therapy for Systemic Sclerosis

The FDA has granted Orphan Drug designation to TLY012 for the treatment of systemic sclerosis.

Recommendations for Diagnosing and Managing Systemic Sclerosis

In this perspective, Tracy M. Frech, MD, MS, discusses the diagnosis and management of systemic sclerosis.

Lung Ultrasound B-Lines May Predict Pulmonary Deterioration in Systemic Sclerosis

Lung ultrasound B-lines can depict modifications in the lung parenchyma of patients with systemic sclerosis and may be an independent predictor of additional pulmonary deterioration in individuals with the disease.

Identifying Potential Biomarkers for Systemic Sclerosis From Skin Biopsies

Using skin biopsy samples, the researchers identified biomarkers and pathways associated with systemic sclerosis pathogenesis.

Ocular Complications Common Across Spectrum of Rheumatic Diseases

Between one-fifth and one-third of patients with rheumatoid arthritis, connective tissue disease, and vasculitis have ocular complications.

World Scleroderma Foundation Preliminary Recommendations for Systemic Sclerosis Management During the COVID-19 Pandemic

The World Scleroderma Foundation developed preliminary guidance based on clinical questions on the SARS-CoV-2 infection for systemic sclerosis management during COVID-19.

Hypertension and Atrial Fibrillation Significantly Associated With Cerebrovascular Accidents in Systemic Sclerosis

Researchers evaluated the association between systemic sclerosis (SSc) and ischemic stroke, and determined risk factors for cerebrovascular accidents in SSc.

Patients With Scleroderma Report Health-Related Barriers to Physical Activity

Researchers identified physical activity barriers and facilitators among patients with scleroderma.